Does TREPROSTINIL Cause Product physical consistency issue? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Product physical consistency issue have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
6
Reports of Product physical consistency issue with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
0
Deaths
1
Hospitalizations
How Dangerous Is Product physical consistency issue From TREPROSTINIL?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Product physical consistency issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Product physical consistency issue?
LEUPROLIDE (926)
CLASCOTERONE (317)
BUPRENORPHINE (242)
MINOXIDIL (171)
CHOLESTYRAMINE (141)
NAPROXEN (117)
TESTOSTERONE (113)
RUXOLITINIB (103)
DEVICE (85)
CLOBETASOL (76)
Which TREPROSTINIL Alternatives Have Lower Product physical consistency issue Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE